Skip to content
Catalyst

PapersPMID:39683570

Curcumin Attenuates Hyperglycemia and Inflammation in Type 2 Diabetes Mellitus: Quantitative Analysis of Randomized Controlled Trial.

Nutrients2024The record ↗

findings
2
compound
1
endpoints
2
  1. Finding, moderate evidencelowersC-reactive protein concentration
  2. Finding, moderate evidencelowersFasting blood glucose
Study, every finding
meta-analysis
Population, every finding
adults with type 2 diabetes
  • “The overall effect estimates from the meta-analysis demonstrated a significant reduction in CRP in curcumin compared to placebo, SMD = −0.59, 95%CI (−1.11, −0.07), p = 0.03.”
    Effect
    −0.59 standardised mean difference, 95% CI −1.11 to −0.07
  • Decreases fasting blood glucose

    moderatereplicated ×6

    “The overall evidence showed a statistically significant reduction in FBG in the T2D group from curcumin compared to placebo MD = −11.48 mg/dL, 95%CI (−14.26, −8.70), p < 0.01.”
    Effect
    −11.48 mean difference, 95% CI −14.26 to −8.7

Study record

Design
meta-analysis
Species
human
Population
Adults with type 2 diabetes, 18 RCTs, 1382 participants (693 curcumin, 689 placebo)
Participants
1,382
Comparator
placebo
Duration
not reported
Endpoints measured
3